International Journal of Radiation Oncology*Biology*Physics
Clinical InvestigationThe Radiation Dose–Response of the Human Spinal Cord
Introduction
Radiation injury to the spinal cord is among the most easily studied experimental models of radiation injury and probably is the most fully documented clinical radiation complication. It has been studied in mice, rats, guinea pigs, dogs, pigs, and monkeys, and it was the subject of more than 400 clinical reports. Nonetheless, owing to its rare clinical manifestation, the clinical dose response has not been established for radiation myelopathy, and the dose–response function at 2-Gy/fraction has been established in animal models only by use of the top-up dose technique (1). This study combines reported data from the literature to establish the parameters of the dose–response function for clinical radiation myelopathy, including the median tolerance dose (D50), and the α/β ratio from the linear-quadratic (LQ) model.
Section snippets
Methods and Materials
In an experimental setting, dose–response data consist of a number of animals at risk and the number of responders at each dose point. For late radiation responses of normal tissues in humans, time to onset of injury must also be known. However, it is possible to circumvent this requirement if the survival experience of the population is known or can be approximated (2). In addition, one must also know the distribution of latent periods (time to onset) for the injury in question (2). In this
Results
A good fit to the combined cervical and thoracic cord data was not possible. Therefore, the different levels were analyzed separately.
Results of the fit of the cervical cord data in Table 1 were D50 = 69.4 Gy, k = 18.8, and α/β = 0.87 Gy. Pearson's chi-square statistic was 2.1 with 5 df, indicating a good fit of the model to the data. The 95% CI for D50 was 66.4–72.6 Gy. The 95% CI for α/β was 0.54–1.19 Gy. The 95% CI for k was 13.3–27.4. Data and the dose–response function are shown in Fig. 1.
Discussion
Values of D50 and calculated values for D05 (the dose at which P = 0.05), P(45 Gy), and P(50 Gy) are in reasonable agreement with previously published estimates based not on statistical analysis, but on extrapolation from animal models combined with some clinical data (24). The dose–response parameters also agree well with large-animal data (21).
The estimated incidence of myelopathy at 45 and 50 Gy seems to fit well with the collective experience. Whereas there are a number of cases of
References (32)
- et al.
The effect of small radiation doses on the rat spinal cord: The concept of partial tolerance
Int J Radiat Oncol Biol Phys
(1983) - et al.
Effect of latency on calculated complication rates
Int J Radiat Oncol Biol Phys
(1986) - et al.
Radiation myelopathy of the cervical spinal cord. Time, dose, and volume factors
Int J Radiat Oncol Biol Phys
(1978) - et al.
Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma
Int J Radiat Oncol Biol Phys
(1980) - et al.
Radiation myelitis and survival in the radiotherapy of lung cancer
Int J Radiat Oncol Biol Phys
(1988) - et al.
Myelopathy following radiotherapy of bronchial carcinoma with large single fractions: A retrospective study
Int J Radiat Oncol Biol Phys
(1983) - et al.
Radiation myelopathy: Estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working Party
Clin Oncol (R Coll Radiol)
(1996) - et al.
Split course radiation in inoperable carcinoma of the bronchus
Eur J Cancer
(1979) - et al.
The incidence of myelitis after irradiation of the cervical spinal cord
Radiology
(1990) - et al.
Radiation tolerance of the cervical spinal cord
Int J Radiat Oncol Biol Phys
(1989)
Radiation myelopathy in primates treated with conventional fractionation
Int J Radiat Oncol Biol Phys
Radiation response of the central nervous system
Int J Radiat Oncol Biol Phys
Hemoglobin, radiation, morbidity and survival
Int J Radiat Oncol Biol Phys
The significance of anemia in clinical radiation therapy
Int J Radiat Oncol Biol Phys
Anemia: A problem or an opportunity in radiotherapy?
Int J Radiat Oncol Biol Phys
Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27
Int J Radiat Oncol Biol Phys
Cited by (0)
This work was supported in part by National Institutes of Health Grant CA 73766.
Conflict of interest: none.